Home › Frost & Sullivan Recognizes KAER's Game-Changing Innovating Aerosol Drug Delivery Methods For High-Dose Respiratory Disease Therapeutics
 

Keywords :   


Frost & Sullivan Recognizes KAER's Game-Changing Innovating Aerosol Drug Delivery Methods For High-Dose Respiratory Disease Therapeutics

2013-02-27 02:15:32| drugdiscoveryonline News Articles

Based on its recent analysis of the aerosol drug delivery technology market, Frost & Sullivan recognizes KAER Biotherapeutics with the 2012 North America Frost & Sullivan Award for Technology Innovation for SUPRAER

Tags: methods delivery drug disease

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
22.11SHIMANO BT Master 11AP)
22.11
22.11
22.11GOLDWIN
22.11Qi10 TOUR 5W WF
22.11
22.11GX HR
22.11 GEORGIA
More »